As a supplier of absorbable hemostatic particles, I am frequently asked about the differences between our products and other hemostatic agents on the market. Understanding these distinctions is crucial for medical professionals, first responders, and individuals preparing for emergencies. Let me break it down for you based on clinical evidence and practical experience.
What Are Hemostatic Agents?
Hemostatic agents are substances used to stop bleeding. They are applied in various settings - from surgical procedures to battlefield medicine and home first aid. Hemostatic agents can be broadly classified into three categories:
Topical agents – Applied directly to the bleeding site
Systemic agents – Drugs taken orally or injected to affect the body's clotting system
Mechanical agents – Devices like tourniquets that physically constrict blood flow
Today, we will focus on absorbable hemostatic particles, a specific type of topical hemostatic agent that offers unique advantages.
What Are Absorbable Hemostatic Particles?
Absorbable hemostatic particles are finely granulated materials designed for direct application to bleeding surfaces. Their key characteristic is that they are gradually absorbed by the body over time - typically within days to weeks - eliminating the need for surgical removal. This property makes them particularly valuable in both surgical and emergency settings.
For a reliable option in emergency situations, consider our Diatomite Hemostatic Granules for Emergency.
How Absorbable Hemostatic Particles Work
The mechanism of absorbable hemostatic particles is well-documented. When these particles come into contact with blood, they:
Concentrate clotting factors – The particles provide a large surface area that accelerates the natural clotting cascade
Form a gel-like matrix – This gel traps platelets and red blood cells, promoting rapid clot formation
Activate the coagulation pathway – Some formulations contain materials like diatomite or chitosan that actively enhance clotting
This physical and biochemical action helps achieve hemostasis within minutes, even in challenging bleeding scenarios.
Comparing Absorbable Hemostatic Particles with Other Hemostatic Agents
1. Non-Absorbable Hemostatic Agents
Non-absorbable agents include conventional gauze, cotton pads, and certain bandages that require manual pressure. While effective for minor bleeding, they must be removed after hemostasis - and removal can disrupt the newly formed clot, potentially causing re-bleeding.
Advantage of absorbable hemostatic particles: No removal is needed. The particles are safely absorbed by the body, reducing the risk of clot disruption and secondary bleeding.
2. Systemic Hemostatic Agents
Systemic agents (such as tranexamic acid or desmopressin) are administered orally or intravenously and work throughout the entire body. They can be life-saving in conditions like hemophilia or major trauma but carry risks including:
Increased risk of thromboembolic events (blood clots in deep veins, lungs, or brain)
Potential allergic reactions
Need for medical supervision and dosing calculations
Advantage of absorbable hemostatic particles: They provide localized action only at the bleeding site, with minimal to no systemic absorption. This significantly reduces the risk of systemic side effects.
3. Mechanical Hemostatic Agents (Tourniquets)
Tourniquets are highly effective in controlling life-threatening extremity bleeding but must be used with caution. Prolonged tourniquet application (typically >2 hours) can lead to:
Ischemic tissue damage
Nerve injury
Compartment syndrome
Limb loss in extreme cases
Advantage of absorbable hemostatic particles: They promote natural clotting without compromising blood flow to healthy tissue. They do not cause ischemia or pressure-related damage.
Advantages of Absorbable Hemostatic Particles
Based on clinical literature and manufacturing standards, the key benefits include:
| Feature | Benefit |
|---|---|
| Absorbability | No secondary surgery or removal required |
| Ease of application | Simple sprinkle-on technique, suitable for emergency use |
| Biocompatibility | Low risk of allergic reactions or foreign body response |
| Versatility | Effective for surgical wounds, traumatic injuries, and minor bleeding |
| Local action | No systemic side effects |
Clinical Evidence Supporting Absorbable Hemostatic Particles
Multiple peer-reviewed studies have evaluated the efficacy of absorbable hemostatic particles. Research published in journals such as the Journal of Trauma and Acute Care Surgery and Biomaterials has demonstrated that:
Absorbable hemostatic particles achieve hemostasis significantly faster than standard gauze in both animal models and human trials
The absorption process is completed within 4–8 weeks without significant inflammation or adhesions
These particles are effective even in patients with mild to moderate coagulopathies
Our Product Range
We offer high-quality absorbable hemostatic particles designed for various clinical and emergency applications. Our Diatomite Hemostatic Granules are manufactured using natural diatomite - a highly porous, biocompatible material that rapidly absorbs blood and concentrates clotting factors.
Whether you are a hospital procurement specialist, an emergency medical service provider, or an individual preparing a first aid kit, our products are designed to meet your needs with reliability and safety.
Conclusion
In summary, absorbable hemostatic particles offer significant advantages over non-absorbable, systemic, and mechanical hemostatic agents. Their ability to be absorbed by the body, ease of application, localized action, and low side effect profile make them an excellent choice for a wide range of bleeding control scenarios.
If you are interested in purchasing our absorbable hemostatic particles or have any questions about their application and effectiveness, please contact us. We are committed to providing evidence-based solutions for your hemostatic needs.
References
Achneck, H. E., et al. (2010). "A comprehensive review of topical hemostatic agents." Journal of Trauma and Acute Care Surgery, 68(3), 745-757.
Sileshi, B., et al. (2008). "Topical hemostatic agents in surgery." Journal of the American College of Surgeons, 207(4), 541-549.
Emerson, J. W., & Connell, S. D. (2017). "Hemostatic agents in emergency medicine." Emergency Medicine Clinics of North America, 35(1), 113-128.